December 8, 2016 — Federal judges have centralized nearly 100 lawsuits involving kidney damage, ketoacidosis, and other side effects of Invokana and Invokamet into a Multi-District Litigation (MDL) in New Jersey.
The U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a transfer order (PDF) for 55 lawsuits and 24 tag-along actions involving canagliflozin, a diabetes drug sold by Janssen Pharmaceuticals.
All of the lawsuits claim these drugs cause a variety of injuries, including diabetic ketoacidosis and kidney damage. The drug-makers are accused of failing to test the drugs for safety or warn about risks.
The lawsuits will be centralized in the U.S. District Court for New Jersey under Judge Brian R. Martinotti — In RE: Invokana (Canagliflozin) Products Liability Litigation — MDL No. 2750.
Invokana was the first member of a new class of diabetes drugs called SGLT2 inhibitors, which treat diabetes by forcing the kidneys to remove more sugar from the body in urine.
The JPML refused to centralize 20 lawsuits involving other SGLT2 inhibitor diabetes drugs like Farxiga (dapagliflozin), Jardiance (empagliflozin), or lawsuits involving a combination of medications.
SGLT2 inhibitors are associated with ketoacidosis, a life-threatening side effect in which the blood becomes too acidic. It was uncommon in people with type-2 diabetes until Invokana was approved in 2013.
Excessive urination can cause dehydration and low blood pressure, and more sugar in the urine can cause severe infections, including life-threatening cases of pyelonephritis or urosepsis. These side effects are both risk-factors for ketoacidosis and kidney failure.
The FDA has issued more warnings for Invokana than other SGLT2 inhibitors. Invokana is associated with higher rates of toe amputations, bone fractures after minor falls, and major cardiovascular events like heart attacks and strokes during the first 30 days of treatment.
Do I have an Invokana Lawsuit?
The Schmidt Firm, PLLC is currently accepting Invokana induced injury cases in all 50 states. If you or somebody you know has been diagnosed with a severe side effect, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.